Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease
- PMID: 24156256
- DOI: 10.2174/15672050113106660166
Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease
Abstract
Oxidative stress is implicated in the pathogenesis of neurodegenerative diseases, including sporadic Alzheimer´s disease (AD). Mitochondrial DNA (mtDNA) deletions are markers of oxidative damage and increase with age. To unravel the impact of mtDNA damage on AD development, we analyzed mtDNA deletion levels in diverse neuronal cell types of four brain regions (hippocampal CA1 and CA2 regions, nucleus tractus spinalis nervi trigemini, and the cerebellum) that exhibit differing levels of vulnerability to AD related changes at progressive Braak stages compared with age-matched controls. Neurons from these four brain regions were collected using laser microdissection, and analyzed using quantitative polymerase chain reaction (qPCR). Although, no correlation between mtDNA deletion levels and AD progression were found, the data revealed regional and cell type specific selective vulnerability towards mtDNA deletion levels. In conclusion, unexpected results were obtained as granule cells from the cerebellum and neurons from the nucleus tractus spinalis nervi trigemini of the brain stem displayed significant higher mtDNA deletion levels than pyramidal cells from hippocampal CA1 and CA2 region in age and AD.
Similar articles
-
Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.J Alzheimers Dis. 2014;40(1):135-42. doi: 10.3233/JAD-131280. J Alzheimers Dis. 2014. PMID: 24334724
-
Astrocyte- and Microglia-Specific Mitochondrial DNA Deletions Levels in Sporadic Alzheimer's Disease.J Alzheimers Dis. 2019;67(1):149-157. doi: 10.3233/JAD-180661. J Alzheimers Dis. 2019. PMID: 30475765
-
Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi.J Alzheimers Dis. 2014;40(2):319-30. doi: 10.3233/JAD-131715. J Alzheimers Dis. 2014. PMID: 24448779
-
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.J Alzheimers Dis. 2006 Jul;9(2):183-93. doi: 10.3233/jad-2006-9210. J Alzheimers Dis. 2006. PMID: 16873965 Review.
-
Mitochondrial involvement in Alzheimer's disease.Biochim Biophys Acta. 1999 Feb 9;1410(2):171-82. doi: 10.1016/s0005-2728(98)00165-0. Biochim Biophys Acta. 1999. PMID: 10076025 Review.
Cited by
-
Mitochondrial Targeting in Neurodegeneration: A Heme Perspective.Pharmaceuticals (Basel). 2018 Sep 18;11(3):87. doi: 10.3390/ph11030087. Pharmaceuticals (Basel). 2018. PMID: 30231533 Free PMC article. Review.
-
Locus specific endogenous retroviral expression associated with Alzheimer's disease.Front Aging Neurosci. 2023 Jul 6;15:1186470. doi: 10.3389/fnagi.2023.1186470. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37484691 Free PMC article.
-
ccf-mtDNA as a Potential Link Between the Brain and Immune System in Neuro-Immunological Disorders.Front Immunol. 2019 May 9;10:1064. doi: 10.3389/fimmu.2019.01064. eCollection 2019. Front Immunol. 2019. PMID: 31143191 Free PMC article. Review.
-
Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology?Int J Mol Sci. 2021 Aug 16;22(16):8769. doi: 10.3390/ijms22168769. Int J Mol Sci. 2021. PMID: 34445475 Free PMC article. Review.
-
Brain pyrimidine nucleotide synthesis and Alzheimer disease.Aging (Albany NY). 2019 Sep 27;11(19):8433-8462. doi: 10.18632/aging.102328. Epub 2019 Sep 27. Aging (Albany NY). 2019. PMID: 31560653 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous